Technical Analysis for AKER - Akers Biosciences Inc

Grade Last Price % Change Price Change
grade F 0.3291 -3.80% -0.01
AKER closed down 3.8 percent on Monday, November 11, 2019, on 1.66 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical AKER trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New Downtrend Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -3.80%
NR7 Range Contraction -3.80%

Older signals for AKER ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Akers Biosciences, Inc. focuses on the development and sale of disposable diagnostic testing devices to facilitate time sensitive therapeutic decisions in the United States and internationally. It provides BreathScan to detect the presence of alcohol in an individual's breath; BreathScan PRO that are single-use detectors, a disposable breath alcohol detector; Metron, a simple breath test for weight loss; PIFA heparin/PF4 rapid assay for detecting heparin-induced thrombocytopenia antibodies; Tri-Cholesterol Test to screen for elevated cholesterol as a risk factor in coronary artery disease; and Vivo, a system for measuring biological markers of oxidative stress non-invasively through a breath test, as well as rapid blood typing cards. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.
Medicine Medical Specialties Antibodies Cholesterol Coronary Artery Disease Glycosaminoglycans Heparin Induced Thrombocytopenia Heparins Thrombocytopenia
Is AKER a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.2
52 Week Low 0.3035
Average Volume 143,220
200-Day Moving Average 0.6449
50-Day Moving Average 0.4261
20-Day Moving Average 0.3873
10-Day Moving Average 0.3668
Average True Range 0.03
ADX 25.65
+DI 5.9006
-DI 24.6775
Chandelier Exit (Long, 3 ATRs ) 0.35
Chandelier Exit (Short, 3 ATRs ) 0.3935
Upper Bollinger Band 0.4389
Lower Bollinger Band 0.3357
Percent B (%b) -0.06
BandWidth 26.646011
MACD Line -0.0229
MACD Signal Line -0.0178
MACD Histogram -0.0051
Fundamentals Value
Market Cap 2.93 Million
Num Shares 8.9 Million
EPS -0.42
Price-to-Earnings (P/E) Ratio -0.78
Price-to-Sales 2.34
Price-to-Book 1.43
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.40
Resistance 3 (R3) 0.40 0.38 0.39
Resistance 2 (R2) 0.38 0.36 0.38 0.39
Resistance 1 (R1) 0.35 0.35 0.34 0.35 0.38
Pivot Point 0.33 0.33 0.32 0.33 0.33
Support 1 (S1) 0.30 0.31 0.29 0.30 0.28
Support 2 (S2) 0.28 0.30 0.28 0.27
Support 3 (S3) 0.26 0.28 0.27
Support 4 (S4) 0.26